8-K
filed February 22, 2023, 6:59 PM ET
ticker BBBY
CIK 0001130713
earnings
confidence high
sentiment negative
materiality 0.75
Overstock Q4 revenue down 34% YoY to $405M; full-year net loss $35M
BED BATH & BEYOND, INC.
2022-FY EPS reported
-$0.83
revenue$1,929,334,000
- Q4 net revenue $405M (-34% YoY); gross margin 22.1%; operating loss $3M.
- Q4 net loss $16M ($0.34 diluted loss per share); adjusted diluted loss $0.04.
- Full-year 2022 net revenue $1.9B (-30% YoY); adjusted EBITDA $63M (3.3% of revenue).
- Active customers 5.2M (-36% YoY); average order value $215 (+4% YoY).
- Repurchased $20M of stock in Q4 at avg $24.76/share; $19.9M remaining under program.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BED BATH & BEYOND, INC. reported Fourth Quarter 2022 results: revenue $405 million, net income $16 million, EPS $0.34.
- Period
- Fourth Quarter 2022
- Revenue
- $405 million
- Net income
- $16 million
- EPS
- $0.34
- Result
- reported results
Exact text from the filing
Total net revenue was $405 million, a decrease of 34% year over year • Gross profit of $90 million, or 22.1% of total net revenue • Operating loss of $3 million • Net loss of $16 million • Diluted net loss per share of $0.34
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
BED BATH & BEYOND, INC. reported Full Year 2022 results: revenue $1.9 billion, net income $35 million, EPS $0.83.
- Period
- Full Year 2022
- Revenue
- $1.9 billion
- Net income
- $35 million
- EPS
- $0.83
- Result
- reported results
Exact text from the filing
Total net revenue of $1.9 billion, a decrease of 30% year over year • Gross profit of $443 million or 23.0% of total net revenue • Operating income of $27 million • Net loss of $35 million • Diluted net loss per share of $0.83
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.